NCT04560478 is a NA clinical trial of Pro Seal Sealant in White Spot Lesion, sponsored by Texas A&M University.

Who is sponsoring NCT04560478?

NCT04560478 is sponsored by Texas A&M University.

What drugs are being tested in NCT04560478?

Interventions in NCT04560478: Pro Seal Sealant, MI Varnish.

What condition does NCT04560478 study?

NCT04560478 studies White Spot Lesion.

Is NCT04560478 still recruiting?

NCT04560478 is currently completed. Last updated 23 September 2020.

Last reviewed 2020-09-23 · How we verify

NCT04560478

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparing Fluoride Varnish and Sealant to Prevent White Spots in Orthodontic Patients

Completed NA Last updated 23 September 2020

What this trial tests

NA trial testing Pro Seal Sealant in White Spot Lesion in 40 participants. Completed in 1 March 2020.

Timeline

1 October 2018

Primary endpoint
10 February 2020

1 March 2020

Quick facts

Lead sponsor	Texas A&M University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	40
Start date	1 October 2018
Primary completion	10 February 2020
Estimated completion	1 March 2020
Sites	1 location across United States

Drugs / interventions tested

Pro Seal Sealant
MI Varnish — full drug profile →

Conditions studied

White Spot Lesion — all drugs for White Spot Lesion →

Sponsor

Texas A&M University

Who can join

Adults 12 to 17, any sex, with White Spot Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is o compare the efficacy of CPP-ACP MI Varnish and ProSeal sealant in preventing white spot lesion (WSL) formation in orthodontic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for White Spot Lesion

Currently open trials in the same condition.

NCT07319884 — The Role of Fluoride Varnish Application in Preventing White Spot Lesions During Clear Aligner Treatment: A Controlled S · NA · active not recruiting

Other Texas A&M University trials

Trials by the same sponsor.

NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
NCT06950775 — The Neighborhood & Health Study · recruiting
NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04560478 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
Last refreshed: 23 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04560478.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing